TCL Archive Five Year Survival Up To 48 Percent; DeVita Has “No Doubt” It Is Really Over 50 Percent Now December 2, 1983
TCL Archive Phase III Tecemotide Trial Fails OS Endpoint; Second Trial Planned After Subgroup Analysis December 27, 2013
TCL Archive Goodfellow To Lead Gynecologic Oncology Research Team At Ohio State University January 11, 2013
TCL Archive GAO Criticizes Distribution Of Comprehensive Cancer Centers, Cite Needs for “Focal Point” Clarification March 26, 1976
